Cambridge Advisors Inc. Johnson & Johnson Transaction History
Cambridge Advisors Inc.
- $446 Million
- Q3 2024
A detailed history of Cambridge Advisors Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Cambridge Advisors Inc. holds 13,096 shares of JNJ stock, worth $2.03 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
13,096
Previous 13,086
0.08%
Holding current value
$2.03 Million
Previous $1.91 Million
10.98%
% of portfolio
0.48%
Previous 0.46%
Shares
29 transactions
Others Institutions Holding JNJ
# of Institutions
4,239Shares Held
1.7BCall Options Held
12.5MPut Options Held
10.3M-
Vanguard Group Inc Valley Forge, PA229MShares$35.5 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY198MShares$30.7 Billion0.67% of portfolio
-
State Street Corp Boston, MA133MShares$20.6 Billion0.86% of portfolio
-
Geode Capital Management, LLC Boston, MA56.1MShares$8.7 Billion0.75% of portfolio
-
Morgan Stanley New York, NY42.1MShares$6.52 Billion0.48% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $405B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...